Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Not yet recruiting	Phase 2	2026-04-02		NCT07507825

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Jiaxing University	36
Dongyang People's Hospital	16
First People's Hospital of Hangzhou	58
Huzhou Central Hospital	31
Jinhua Central Hospital	29
Jinhua People's Hospital	11
Ningbo Medical Center Lihuili Hospital	61
Second Affiliated Hospital of Wenzhou Medical University	81
Shaoxing People's Hospital	24
Shaoxing Second Hospital	6
Taizhou Hospital	28
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University	28
The Affiliated People's Hospital of Ningbo University	21
The Central Hospital of Lishui City	21
The Second Affiliated Hospital of Jiaxing University	22
Yuyao People's Hospital	5
Zhejiang Provincial Tongde Hospital	20
Zhejiang University	194

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University	Hangzhou	China	5